ABOS
ABOS
Positions held
Your positionsABOS isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
Headlines — positive tone
• [OK · fundamentals] All You Need to Know About Acumen Pharmaceuticals (ABOS) Rating Upgrade to Buy
News
2026-09-21 · 4 Alzheimer's Drug Stocks to Watch on World Alzheimer's Day
2026-09-10 · Acumen Pharmaceuticals to Hold Virtual Investor Day on September 16, 2026
2026-09-02 · Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences
2026-08-12 · Acumen Pharmaceuticals Inc (ABOS) (Q2 2026) Earnings Call Highlights: Advancing Sabirnetug ...
2026-08-12 · Acumen Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
2026-08-12 · Acumen Pharmaceuticals Q2 Earnings Call Highlights
2026-08-12 · Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
2026-08-05 · Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026
2026-07-31 · Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?
2026-07-20 · VERAXA Biotech Shows Regulatory Progress on Cancer Therapy Platform
2026-07-16 · Slate Medicines Appoints Mark W. Hahn to Board of Directors
2026-07-15 · All You Need to Know About Acumen Pharmaceuticals (ABOS) Rating Upgrade to Buy
Price (daily)
Full chart · RSI · MACD · patterns